Long-term efficacy and safety of hydroquinidine in patients with Brugada syndrome

Back

ESC Premium Access

Long-term efficacy and safety of hydroquinidine in patients with Brugada syndrome

Session: Risk of Sudden Cardiac Death in Patient with Ion Channel Disorders

Topic: Antiarrhythmic Drug Treatment

Speaker: Doctor F. Angelini (Turin, IT)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Filippo Angelini

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

0 follower

5 more presentations in this session

ICD implantation and device therapy: Fabry vs hypertrophic cardiomyopathy

Speaker: Doctor R. Vijapurapu (Stoke-on-Trent, GB)

Access

Abstract

Slides

Splice site mutation of LMNA causes severe dilated cardiomyopathy via strong dominant reduction of total lamin expression

Speaker: Doctor K. Kato (Otsu, JP)

Access

Abstract

Slides

Role of an extensive diagnostic work-up in the detection of concealed cardiomyopathies in athletes with premature ventricular complexes and implications for sports' eligibility assessment

Speaker: Doctor P. Compagnucci (Ancona, IT)

Access

Abstract

Slides

KCNQ1 V141M and Short QT Syndrome: Are we dealing with a different entity?

Speaker: Doctor G. Garcia Ordonez (Ciudad de Mexico, MX)

Access

Abstract

Slides

Molecular mechanism of a new cardiac syndrome associated with a regulatory element deletion of chromosome 4q25

Speaker: Ms M. Baudic (Nantes, FR)

Access

Abstract

Slides

Access the full session

Risk of Sudden Cardiac Death in Patient with Ion Channel Disorders

Speakers: Doctor F. Angelini, Doctor R. Vijapurapu, Doctor K. Kato, Doctor P. Compagnucci, Doctor G. Garcia Ordonez...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources